Aura Biosciences, Inc. AURA Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s short- and long-term operating lease liabilities?
- Aura Biosciences, Inc. (AURA) reported short- and long-term operating lease liabilities of -$386K in Q1 2026.
- How has Aura Biosciences, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Aura Biosciences, Inc.'s short- and long-term operating lease liabilities decreased by 18.8% year-over-year, from -$325K to -$386K.
- What is the long-term trend for Aura Biosciences, Inc.'s short- and long-term operating lease liabilities?
- Over 2 years (2023 to 2025), Aura Biosciences, Inc.'s short- and long-term operating lease liabilities has grown at a 2.6% compound annual growth rate (CAGR), from -$1.32M to -$1.39M.